版本:
中国

BRIEF-Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma

March 27 Delcath Systems Inc

* Delcath announces special protocol assessment agreement with FDA for pivotal trial with Melphalan/HDS in intrahepatic cholangiocarcinoma Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐